Stephens Inc’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.51M Buy
3,392
+77
+2% +$34.3K 0.02% 522
2025
Q1
$1.61M Sell
3,315
-138
-4% -$66.9K 0.02% 517
2024
Q4
$1.39M Sell
3,453
-95
-3% -$38.3K 0.02% 524
2024
Q3
$1.65M Sell
3,548
-160
-4% -$74.4K 0.02% 485
2024
Q2
$1.74M Sell
3,708
-360
-9% -$169K 0.03% 459
2024
Q1
$1.7M Buy
4,068
+43
+1% +$18K 0.03% 458
2023
Q4
$1.64M Sell
4,025
-320
-7% -$130K 0.03% 440
2023
Q3
$1.51M Sell
4,345
-59
-1% -$20.5K 0.03% 440
2023
Q2
$1.55M Sell
4,404
-300
-6% -$106K 0.03% 441
2023
Q1
$1.48M Buy
4,704
+274
+6% +$86.3K 0.03% 456
2022
Q4
$1.28M Sell
4,430
-274
-6% -$79.1K 0.03% 463
2022
Q3
$1.36M Sell
4,704
-1,755
-27% -$508K 0.03% 453
2022
Q2
$1.82M Sell
6,459
-1,000
-13% -$282K 0.04% 403
2022
Q1
$1.95M Sell
7,459
-4,044
-35% -$1.06M 0.03% 427
2021
Q4
$2.53M Sell
11,503
-2,496
-18% -$548K 0.04% 404
2021
Q3
$2.54M Sell
13,999
-3,588
-20% -$651K 0.04% 407
2021
Q2
$3.55M Sell
17,587
-74
-0.4% -$14.9K 0.05% 360
2021
Q1
$3.8M Buy
17,661
+2,058
+13% +$442K 0.06% 306
2020
Q4
$3.69M Buy
15,603
+2,730
+21% +$645K 0.07% 292
2020
Q3
$3.5M Buy
12,873
+1,939
+18% +$528K 0.07% 274
2020
Q2
$3.17M Buy
10,934
+2,465
+29% +$716K 0.07% 281
2020
Q1
$2.02M Sell
8,469
-211
-2% -$50.2K 0.05% 344
2019
Q4
$1.9M Sell
8,680
-1,980
-19% -$433K 0.04% 411
2019
Q3
$1.81M Sell
10,660
-309
-3% -$52.4K 0.04% 409
2019
Q2
$2.01M Sell
10,969
-371
-3% -$68K 0.05% 401
2019
Q1
$2.09M Sell
11,340
-533
-4% -$98K 0.05% 390
2018
Q4
$1.97M Buy
11,873
+200
+2% +$33.1K 0.06% 358
2018
Q3
$2.25M Buy
+11,673
New +$2.25M 0.06% 374
2017
Q3
Sell
-13,315
Closed -$1.72M 877
2017
Q2
$1.72M Buy
13,315
+143
+1% +$18.4K 0.06% 322
2017
Q1
$1.44M Buy
+13,172
New +$1.44M 0.05% 348
2013
Q3
Sell
-2,920
Closed -$234K 846
2013
Q2
$234K Buy
+2,920
New +$234K 0.01% 601